SCHEMBL17322114

SCHEMBL17322114

c1ccc(-c2nc(-c3ccc(-c4ccncc4)cc3)cc(-c3ccc(-n4c5ccccc5c5ccc6c(c54)-c4cccc5cccc-6c45)cc3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ HPGD P15428 5/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ KMT2A Q03164 7/20 0.34
▸ MEN1 O00255 6/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ LMNA P02545 4/20 0.33
▸ MAPK1 P28482 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17322109 0.95 KMT2A (0.36) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322112 0.95 KMT2A (0.36) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17321878 0.94 HPGD (0.36) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322099 0.94 HPGD (0.36) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322107 0.92 HPGD (0.36) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322108 0.92 DHODH (0.38) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322113 0.92 DHODH (0.38) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322117 0.91 DHODH (0.37) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL20725455 0.91 PDE6D (0.32) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL17322111 0.90 MAPT (0.34) MAPTALDH1A1HPGDKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150357576-A1 CONDENSED FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL INCLUDING SAME, ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2015-12-10 — — US disclosed
US-20150357576-A1 CONDENSED FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL INCLUDING SAME, ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150357576-A1 CONDENSED FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL INCLUDING SAME, ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME, AND ELECTRONIC DEVICE AFF2, AFF4, AFF1 MAPT 1810/4885ALDH1A1 2550/4885HPGD 3075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback